CVS was accused of overbilling Medicaid and other government reimbursement programs for insulin pen prescriptions from 2010 to 2020. The company will pay a combined total of $36.5 million, plus interest, under the agreement.
Source: Hawaii News Now
Indexed: Sat, 04 Jul 2026 20:33:25 UTC
Not a government entity. Not a broker or agent. Public information index only. Verify independently.